Pembrolizumab-Induced Thyroiditis

Am J Ther. 2023 May 1;30(3):e291-e293. doi: 10.1097/MJT.0000000000001367.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Humans
  • Thyroiditis* / chemically induced
  • Thyroiditis* / diagnosis

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized